MilliporeSigma opens $3.45M biosafety testing facility in Rockville

MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany, has opened its new $3.45 million biosafety testing facility in Rockville. Biosafety testing and analytical development are fundamental components of drug development and commercialization for traditional and novel modalities. Global demand for these services is growing at a double-digit rate.